Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

Comparing Major Adverse Kidney Events (MAKE) Among New Users of Oral Semaglutide (SEMA) Versus Select Oral Antidiabetic Medications (ADMs) Among US Adults With Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)

Authors :

Lin Xie¹; Guanghao Zhang¹; Sherif Mehanna¹; Josh Noone¹; Caroline Swift¹; Matthew Weir^2,3

Affiliations

View Details Hide Details

Download .PDF

Keywords

Diabetes

Congress poster

GLP-1 RA

Semaglutide (oral)

RWE HEOR